Worcester medical device maker Interscope Inc. announced late Tuesday that it received clearance from the U.S. Food and Drug Administration for its EndoRotor System to commercialize in gastroenterology and colorectal surgery.
The EndoRotor is the first flexible microdebrider for use by medical specialists in the digestive tract to completely remove diseased mucosa. It performs tissue dissection, resection and retrieval in one step, which enables endoscopists to remove the disease without thermal energy.
Endoscopic Mucosal Resection is a technique to remove superficial neoplasms of the GI tract with the goal of stopping disease progression. The majority of mucosal neoplasms are non-malignant, but the risk of malignancy increases with polyp size.
The company received the CE Mark in October 2015, allowing it to market the EndoRotor in the European Union.
